A research team at Korea University's Vaccine Innovation Center (Center Director Jung Hee-jin) announced promising results in research on mRNA vaccine development to prevent hantavirus infections.In a ...

When Jessamyn Butler would get nosebleeds as a child, her mother would tell her the length of the bleed was normal, no matter ...

Officials said that culling operations have begun in two districts of Mizoram to prevent further spread of the disease in the ...

Reporter [email protected] If you have been hunting whitetail deer in Pennsylvania for any amount of time, you are likely familiar with the term Epizootic Hemorrhagic Disease, commonly ...

A recent CDC health alert warned travelers of high rates of dengue fever in the Americas. Here's what you need to know about ...

A 25-year-old female National Youth Service Corps (NYSC) member has died of Lassa fever in Ogun State. The tragic incident ...

The UK Health Security Agency (UKHSA) has identified 24 infectious diseases that pose the greatest future threats to public health. Some, like COVID-19, have pandemic ...

Wild animals thrive better in the wild where they have plenty of natural habitat with FWP noting it’s safer for humans to ...

As of February 16, there were 431 cases and 53 deaths in two outbreaks in remote villages in different health zones in ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...